Eurofins Scientific (ERFN) Income Statement
Eurofins Scientific Income Statement
Last quarter (Q2 2026), Eurofins Scientific's total revenue was $3.70B, an increase of 8.26% from the same quarter last year. In Q2, Eurofins Scientific's net income was $302.00M. See Eurofins Scientific’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 7.30B | $ 6.95B | $ 6.51B | $ 6.71B | $ 6.72B | |
| $ 896.70M | $ 4.71B | $ 620.40M | $ 4.49B | $ 4.57B | |
| $ 78.40M | $ 3.99B | $ 73.60M | $ 3.70B | $ 3.30B | |
| Depreciation and Amortization | $ 630.00M | $ 691.40M | $ 664.30M | $ 607.20M | $ 525.20M |
| $ 1.45B | $ 1.39B | $ 1.22B | $ 1.49B | $ 1.88B | |
| $ 818.30M | $ 726.20M | $ 546.80M | $ 783.20M | $ 1.28B | |
| $ -139.00M | $ -171.60M | $ -123.50M | $ -3.20M | $ -218.70M | |
| $ 654.00M | $ 554.60M | $ 423.30M | $ 780.00M | $ 1.06B | |
| $ 475.00M | $ 406.40M | $ 310.30M | $ 610.20M | $ 782.60M | |
| Per Share Metrics | |||||
| Basic EPS | $ 2.64 | $ 2.13 | $ 1.61 | $ 3.17 | $ 4.09 |
| Diluted EPS | $ 2.54 | $ 2.09 | $ 1.57 | $ 3.07 | $ 3.90 |
| Weighted Average Shares Outstanding | 180.00M | 190.60M | 192.90M | 192.50M | 191.50M |
| Weighted Average Shares Outstanding (Diluted) | 187.00M | 194.50M | 197.90M | 199.00M | 200.60M |
Currency in EUR
